Delivery Order SPE2DR25D2009-SPE2DR26FJ5E3
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of REPATHA 140 mg/ml SureClick auto-injectors, valued at $1,041.42. This is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and represents a non-competitive set-aside award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $11,808.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of December 10, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. REPATHA is a prescription medication used to treat high cholesterol, and...
- The Defense Logistics Agency awarded a delivery order valued at $1,735.27 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors. The award, issued on December 30, 2025, with a completion date of December 31, 2025, represents a firm fixed-price delivery against AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. This delivery order is unset-aside and competitively sourced, consistent with AmerisourceBergen's standard federal...
- The Defense Logistics Agency awarded a $18,426.38 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for REPATHA 140 MG/ML SureClick auto-injector pharmaceutical products, with final delivery due by December 8, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The contract involves...
- The Defense Logistics Agency awarded a delivery order valued at $8,232.28 to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors, with an ultimate completion date of August 13, 2025. This competitive, firm fixed-price delivery order represents a continuation of pharmaceutical supply under AmerisourceBergen's existing contract vehicle with DLA. The award carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $44,057.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injector pens on December 11, 2025, with an ultimate completion date of December 12, 2025. This non-set-aside contract represents a competitive award to the prime contractor, which is headquartered in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $2,859.55 to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors, with an ultimate completion date of April 23, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical vendor that...
- The Defense Logistics Agency awarded a $5,181.96 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 MG/ML SureClick auto-injector pharmaceuticals, with an ultimate completion date of October 16, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency awarded a delivery order valued at $2,254.40 to AmerisourceBergen Drug Corp for the supply of REPATHA 140 mg/ml SureClick auto-injectors. The contract, awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a firm fixed price delivery order with no set-aside designation. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters and serves as a...
- The Defense Logistics Agency awarded a $4,540.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of September 16, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply vehicle running through December 2026. The place of performance is...
- SPE2DR25D2009Indefinite Delivery Contract
- SPE2DR25D2009-SPE2DR26FJ5E3Delivery Order
The Defense Logistics Agency awarded a $18,521.79 firm fixed-price delivery order to AmerisourceBergen Drug Corp (Conshohocken, PA) on January 13, 2026, for the supply of REPATHA 140 mg/ml SureClick auto-injectors, with completion scheduled for January 14, 2026. This non-competitive delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements. The award is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.99 million through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to military healthcare systems globally. AmerisourceBergen, one of the nation's largest pharmaceutical distributors, maintains a significant role in the Defense Health Agency's medical supply chain through this comprehensive IDC arrangement. The contract vehicle supports military treatment facilities and veterans' healthcare programs by enabling efficient fulfillment of recurring pharmaceutical needs across multiple therapeutic domains. This delivery order for REPATHA, a cardiovascular medication used for cholesterol management, exemplifies the routine task order activity flowing through the larger pharmaceutical prime vendor contract, which continues to be a critical mechanism for ensuring reliable access to essential medications and medical supplies across the Department of Defense medical enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.5k | 1/12/26 |